
Sitaglyn M 50/500 Tablet PR
Marketer
Zydus Healthcare Limited
Salt Composition
Sitagliptin (50mg) + Metformin (500mg)
Overview Sitaglyn M 50/500 Tablet PR
Diabetic patients with type 2 mellitus may find relief from elevated blood glucose levels with Sitaglyn M 50/500 PR tablets, a dual-action medication. This formulation helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Sitaglyn M 50/500 PR can be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is tailored to individual health status, glycemic control, and concurrent medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Maintaining the prescribed diet and exercise regimen is crucial for diabetes management. Common adverse effects include nausea, vomiting, diarrhea, abdominal distress, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; prompt identification and management of low blood sugar is essential. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or excessive alcohol consumption. Pregnant or lactating individuals should seek medical advice before use. Interaction with other drugs is possible; complete disclosure of all medications to your doctor is vital for safety. Alcohol should be avoided due to its potential to decrease blood glucose. Kidney function and blood sugar monitoring will be conducted before, during, and after treatment.
Primary Ingredients of Sitaglyn M 50/500 Tablet PR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Sitaglyn M 50/500 Tablet PR
Managing Type 2 Diabetes
Major Benefits of Sitaglyn M 50/500 Tablet PR:
Follow your doctor's instructions or consult the product label for proper administration. Take Sitaglyn M 50/500 Tablet PR with a meal.
Common Side effects of Sitaglyn M 50/500 Tablet PR:
- Decreased appetite
- Vomiting
- Upper respiratory tract infection
- Hypoglycemia (low blood glucose level)
- Abdominal bloating
- Nausea
- Diarrhea
How to use Sitaglyn M 50/500 Tablet PR:
Follow your physician's instructions or consult the product label for dosage guidance. Administer Sitaglyn M 50/500 Tablet PR with a meal.
How Sitaglyn M 50/500 Tablet PR works:
Sitaglyn M 50/500 tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves the body's insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and augmenting insulin sensitivity. This dual action leads to improved glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sitaglyn M 50/500 Tablet PR with alcohol is not advised due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Sitaglyn M 50/500 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential benefits against the risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Sitaglyn M 50/500 Tablet PR while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Patients with kidney impairment should use Sitaglyn M 50/500 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Sitaglyn M 50/500 Tablet PR is contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverUNSAFE
Patients with liver conditions should likely avoid Sitaglyn M 50/500 Tablet PR, as its use may be unsafe. A physician's consultation is recommended.
What if you forget to take Sitaglyn M 50/500 Tablet PR :
Should you forget a dose of Sitaglyn M 50/500 Tablet PR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sitaglyn M 50/500 Tablet PR
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Diabetes Management |